Overview
Determinants of Outcome in Patients with Staphylococcus aureus Bacteremia
Antibacterial Resistance
Pathogenesis of Bacterial Infections
Tropical medicine/International Health
Antibacterial Resistance
Pathogenesis of Bacterial Infections
Tropical medicine/International Health
Current Duke Appointments & Affiliations
Florence McAlister Distinguished Professor of Medicine
·
2019 - Present
Medicine, Infectious Diseases,
Medicine
Professor of Medicine
·
2012 - Present
Medicine, Infectious Diseases,
Medicine
Professor in Molecular Genetics and Microbiology
·
2012 - Present
Molecular Genetics and Microbiology,
Basic Science Departments
Member in the Duke Clinical Research Institute
·
2001 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Rationalizing Heterogeneity in Staphylococcus aureus Bacteremia: Current Progress and Future Goals.
Journal article J Infect Dis · September 23, 2026 Clinical and biological heterogeneity in Staphylococcus aureus bacteremia (SAB) continue to pose significant challenges for the clinical management of individual patients and for research efforts. We contend that investigating SAB as a single disease is im ... Full text Link to item CiteEconomic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial.
Journal article Clin Infect Dis · September 17, 2026 OBJECTIVE: The DOTS trial demonstrated similar clinical outcomes among 200 adults with complicated Staphylococcus aureus bacteremia (SAB) randomized to two doses of dalbavancin or standard-therapy antibiotics after initial clearance. We aimed to determine ... Full text Link to item CiteInfective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association.
Journal article Circulation · September 8, 2026 Since the publication of the 2015 American Heart Association scientific statement on infective endocarditis, its incidence has increased, its epidemiology has changed, and novel diagnostic and treatment options have become available. Updated case definitio ... Full text Link to item CiteRecent Grants
2/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Center for Advancing Translational Sciences · 2025 - 2030Genomic determinants of antibiotic treatment failure in S. aureus bacteremia
ResearchMentor · Awarded by National Institutes of Health · 2024 - 2029A PHASE 3 EFFICACY AND SAFETY STUDY OF FOSMANOGEPIX FOR THE TREATMENT OF ADULT PARTICIPANTS WITH INVASIVE MOLD INFECTIONS
ResearchInvestigator · Awarded by Basilea Pharmaceutica · 2026 - 2029View All Grants
Education
Duke University ·
1999
M.H.S.
University of North Carolina, Chapel Hill ·
1993
M.D.